Web Analytics

3 Latest Announced Rounds

  • $67,000,000
    Series A
    Biotechnology Research
    Apr 2nd, 2025
  • $10,000,000
    Seed

    2 Investors

    Software Development
    Apr 2nd, 2025
  • $5,200,000
    Series A

    3 Investors

    Technology, Information and Internet
    Apr 2nd, 2025
$1,286.67M Raised in 37 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Be Biopharma

start up
United States - Cambridge, Massachusetts
  • 23/10/2024
  • Unknown
  • $82,000,000

Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies.


Related People

Joanne Smith-FarrellFounder

Joanne Smith-Farrell United States - Greater Boston

N/A